Open AccessTriamcinolone acetonide combined with aminoguanidine inhibits inflammation and oxidative stress, improves vascular endothelial and retinal function and reduces VEGF expression in diabetic retinopathy patients
Author(s) -
Kai Xu,
Hanliang Qian,
Meibo Zou
Publication year - 2020
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2020.8478
Subject(s) - diabetic retinopathy , vascular endothelial growth factor , triamcinolone acetonide , medicine , malondialdehyde , oxidative stress , endocrinology , retinopathy , superoxide dismutase , diabetes mellitus , immunology , vegf receptors